Latest Period
Q1 2026
Security Snapshot
Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (TNGX) Institutional Ownership
CUSIP: 87583X109
13F Institutional Holders and Ownership History from Q3 2021 to Q1 2026
Institutions Reporting
191
Shares (Excl. Options)
180,109,181
Price
$20.92
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- TNGX on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 180,109,181
- Total 13F value
- $3,767,380,758
- Portfolio coverage rank
- 0.01%
- Share change
- +7,724,763
- Value change
- +$250,199,024
- Number of holders
- 191
- Shares outstanding
- 143,181,938
- SEC-reported price per share
- $20.00
- Insider filing price
- $20.00
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- TNGX - Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 87583X109.
- 191 institutions reported positions in Q1 2026.
- 11 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 170 to 191 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $1,527,338,138 to $3,767,380,758.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 191 institutions filings for Q1 2026.
Security key
87583X109
Latest holder period
Q1 2026
13F holders
191
13D/G owners
11
CIK / CUSIP context first
Open Q1 2026 holders
TNGX full holder history
Tango Therapeutics, Inc. SEC filings
Tango Therapeutics, Inc. company facts
Tango Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 87583X109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
11
Security
TNGX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FARALLON PARTNERS L L C/CA | 10% | $119,266,365 | 13,461,215 | Dapice Joshua J. | 31 Dec 2025 | |||
| RTW INVESTMENTS, LP | 9.3% | $278,248,970 | 13,300,620 | RTW Investments, LP | 31 Mar 2026 | |||
| Adage Capital Management, L.P. | 9% | +14% | $267,974,426 | +$46,056,656 | 12,809,485 | +21% | Adage Capital Management, L.P. | 31 Mar 2026 |
| TCG Crossover GP II, LLC | 8.1% | -19% | $242,624,658 | -$40,252,214 | 11,597,737 | -14% | TCG Crossover GP II, LLC | 31 Mar 2026 |
| Farallon Capital Partners, L.P. | 7.8% | -19% | $235,500,687 | +$10,464,247 | 11,257,203 | +4.7% | Dapice Joshua J. | 31 Mar 2026 |
| FMR LLC | 6.9% | $207,231,825 | +$206,951,665 | 9,905,919 | +73869% | FMR LLC | 31 Mar 2026 | |
| BlackRock, Inc. | 6.3% | +26% | $75,107,682 | +$26,758,396 | 8,477,165 | +55% | BlackRock, Inc. | 31 Dec 2025 |
| Woodline Partners LP | 5.6% | -24% | $167,360,272 | -$43,350,675 | 8,000,013 | -21% | Woodline Partners LP | 31 Mar 2026 |
| Nextech Crossover I GP S.a r.l. | 5.1% | $152,006,415 | 7,266,081 | Nextech Crossover I GP S.a. r.l. | 31 Mar 2026 | |||
| Third Rock Ventures IV, L.P. | 4.7% | -18% | $74,901,244 | -$17,625,000 | 6,374,574 | -19% | Third Rock Ventures IV, L.P. | 06 Feb 2026 |
| Invus Global Management, LLC | 4% | -35% | $118,346,637 | -$52,472,987 | 5,657,105 | -31% | Raymond Debbane | 31 Mar 2026 |
As of 31 Mar 2026, 191 institutional investors reported holding 180,109,181 shares of Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (TNGX). This represents 126% of the company’s total 143,181,938 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
106%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 9.3% | 13,300,620 | +792% | 2.8% | $278,248,970 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 8.9% | 12,809,485 | +21% | 0.41% | $267,974,426 |
| Boxer Capital Management, LLC | 7.6% | 10,876,219 | 0% | 30% | $227,530,501 |
| TCG Crossover Management, LLC | 7.4% | 10,531,071 | -17% | 6.3% | $220,310,005 |
| FMR LLC | 6.9% | 9,905,919 | +245% | 0.01% | $207,231,826 |
| FARALLON CAPITAL MANAGEMENT LLC | 6.4% | 9,097,411 | -30% | 1.2% | $190,317,838 |
| BlackRock, Inc. | 6.1% | 8,748,045 | +2.4% | 0% | $183,009,100 |
| Woodline Partners LP | 5.6% | 8,000,013 | -21% | 0.63% | $167,360,272 |
| Nextech Invest, Ltd. | 5.1% | 7,266,081 | 0% | 11% | $152,006,415 |
| TRV GP IV, LLC | 4.5% | 6,374,574 | -19% | 50% | $133,356,088 |
| Siren, L.L.C. | 4% | 5,657,105 | -31% | 3.3% | $118,346,637 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.6% | 5,161,431 | 0% | 0% | $107,977,137 |
| GOLDMAN SACHS GROUP INC | 3.5% | 5,076,392 | +2.7% | 0.01% | $106,198,121 |
| STATE STREET CORP | 3.2% | 4,651,894 | -25% | 0% | $97,317,622 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2.9% | 4,146,813 | +43% | 1% | $86,751,328 |
| Paradigm Biocapital Advisors LP | 2.8% | 4,009,679 | 1.7% | $83,882,485 | |
| Holocene Advisors, LP | 2.7% | 3,932,603 | 0.2% | $82,270,055 | |
| Balyasny Asset Management L.P. | 2.7% | 3,826,659 | -28% | 0.16% | $80,053,706 |
| Logos Global Management LP | 2.1% | 3,000,000 | -29% | 3.2% | $62,760,000 |
| Deep Track Capital, LP | 1.9% | 2,750,000 | +12% | 1.2% | $57,530,000 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 2,675,777 | +4.8% | 0% | $55,990,239 |
| Caligan Partners LP | 1.7% | 2,408,798 | -35% | 3.6% | $50,392,054 |
| Bellevue Group AG | 1.7% | 2,400,000 | -39% | 1.2% | $50,208,000 |
| JANUS HENDERSON GROUP PLC | 1.7% | 2,394,972 | -9.4% | 0.02% | $50,066,890 |
| Vivo Capital, LLC | 1.5% | 2,154,780 | 0% | 3.7% | $45,077,998 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
19
Latest
Q1 2026
Rows shown
1-19 of 19
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 180,109,181 | $3,767,380,758 | +$250,199,024 | $20.92 | 191 |
| 2025 Q4 | 172,390,699 | $1,527,338,138 | +$294,868,824 | $8.86 | 170 |
| 2025 Q3 | 139,967,069 | $1,175,703,546 | +$109,407,056 | $8.40 | 140 |
| 2025 Q2 | 127,196,008 | $651,244,300 | +$113,427,538 | $5.12 | 114 |
| 2025 Q1 | 107,228,944 | $146,966,295 | -$1,500,604 | $1.37 | 119 |
| 2024 Q4 | 106,381,203 | $328,721,243 | -$120,601,739 | $3.09 | 134 |
| 2024 Q3 | 101,459,260 | $781,203,088 | -$3,564,439 | $7.70 | 119 |
| 2024 Q2 | 98,595,824 | $845,901,469 | +$2,628,498 | $8.58 | 116 |
| 2024 Q1 | 98,377,909 | $781,109,580 | +$30,778,538 | $7.94 | 124 |
| 2023 Q4 | 93,643,916 | $927,104,831 | +$41,143,001 | $9.90 | 118 |
| 2023 Q3 | 88,799,639 | $999,861,944 | +$236,872,193 | $11.26 | 99 |
| 2023 Q2 | 68,320,832 | $226,845,382 | -$7,737,842 | $3.32 | 89 |
| 2023 Q1 | 69,836,747 | $275,851,159 | +$1,770,332 | $3.95 | 91 |
| 2022 Q4 | 68,766,073 | $498,554,976 | +$12,927,727 | $7.25 | 83 |
| 2022 Q3 | 68,157,717 | $246,729,459 | -$12,119,590 | $3.62 | 86 |
| 2022 Q2 | 70,452,006 | $319,137,805 | -$11,072,751 | $4.53 | 76 |
| 2022 Q1 | 69,679,958 | $528,174,476 | +$13,385,662 | $7.58 | 70 |
| 2021 Q4 | 67,775,150 | $740,996,532 | +$24,899,642 | $10.94 | 57 |
| 2021 Q3 | 65,465,348 | $844,863,000 | +$844,863,000 | $12.93 | 45 |